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Abstract
Background Previous studies show that ‘poor responders’
to Roux-en-Y gastric bypass (RYGBP) may be identified
on the basis of early postoperative weight loss. Early
identification of poor responders could allow earlier pro-
vision of postoperative behavioural and/or intensive life-
style interventions and enhance their maximal weight loss.
Our aim was to investigate whether early postoperative
weight loss predicts the maximal weight loss response after
RYGBP and sleeve gastrectomy (SG).
Methods We undertook a retrospective cross-sectional
study of 1,456 adults who underwent either RYGBP
(n = 918) or SG (n = 538) as a primary procedure in one
of two European centres. Postoperative weight loss was
expressed as weight loss velocity (WLV) and percentage
weight loss. Linear regression analyses were performed to
determine the association of early postoperative weight
loss with maximal %WL, including adjustment for baseline
variables.
Results There was marked variability in maximal %WL
following both RYGBP (mean 32.9 %, range 4.1–60.9 %)
and SG (mean 26.2 %, range 1.1–58.3 %). WLV
3–6 months postoperatively was more strongly associated
with maximal %WL (r2 = 0.32 for RYGBP and r2 = 0.26
for SG, P \ 0.001 for both) than either WLV 0–6 weeks or
6 weeks to 3 months postoperatively (r2 = 0.14 and 0.10
for RYGBP, respectively; r2 = 0.18 and 0.21 for SG,
respectively; P \ 0.001 for all). Multiple linear regression
analysis, including baseline variables of age, sex, preop-
erative BMI, type 2 diabetes, ethnicity, and bariatric centre,
revealed that 3–6 month WLV was an independent pre-
dictor of maximal %WL in both SG and RYGBP groups
(standardised b-coefficients 0.51 and 0.52, respectively;
P \ 0.001 for both).
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Conclusions There is a marked variability in weight loss
response following RYGBP and SG. Early postoperative
weight loss can be used to identify patients whose predicted
weight loss trajectories are suboptimal. Early targeting of
poor responders with more intensive postoperative lifestyle
and behavioural support could potentially enhance their
weight loss response.
Keywords Obesity  Bariatric surgery  Roux-en-Y
gastric bypass  Sleeve gastrectomy  % weight loss  BMI
Bariatric surgery is currently the most effective weight loss
intervention for patients with severe obesity, is cost-effective,
and significantly reduces morbidity and mortality [1, 2]. Roux-
en-Y gastric bypass (RYGBP) is considered the ‘gold standard’
procedure with the most robust long-term clinical outcome data
[1]; however, sleeve gastrectomy (SG) is fast attaining the
status of a valid alternative to RYGBP [3], overtaking adjust-
able gastric banding (AGB) in the hierarchy of bariatric sur-
gical interventions [4]. All three bariatric procedures lead to
sustained weight loss and amelioration of obesity-related
comorbidities that is unrivalled by medical interventions [5, 6].
There is, however, a wide variability in the weight loss response
to RYGBP and AGB, though unknown for SG [7–9], with
maximal weight loss occurring at 12–18 months postopera-
tively in the majority of patients [8–10].
Previous studies have identified preoperative clinical
factors that are associated with reduced weight loss after
bariatric surgery, although primarily for RYGBP. For
example, higher baseline BMI, male sex, and older age are
consistent predictors of suboptimal weight loss [7, 11–18].
Of note, relatively few studies have examined the effects of
such factors in relation to SG [16]. However, these clinical
factors explain only a small proportion of the observed
variability in weight loss [7]. Given the lack of powerful
preoperative predictors of weight outcomes, it is notable that
‘poor responders’ to RYGBP and AGB may be identified
early in the postoperative period on the basis of early weight
change patterns [19–21]. However, whether early postop-
erative weight loss also predicts long-term weight outcomes
for SG is unknown. Importantly, postoperative behavioural
or intensive lifestyle interventions improve weight loss after
bariatric surgery [22–24], thus early identification of poor
responders is an important focus for postoperative care. The
aims of the study were thus to investigate whether early
postoperative weight loss is an important predictor of the
maximal weight loss response after RYGBP or SG, to
identify early weight change patterns that are most predictive
of maximal %WL, and to explore whether variability in
weight loss after SG is similar to that observed after RYGBP.
Methods
Study subjects and design
This study was designed as a retrospective cohort study.
Data were obtained by review of prospectively maintained
electronic clinical data records and clinical case notes within
two European university hospital bariatric surgery centres.
Patients aged 18 or over, with a BMI C40.0 kg/m2, or
C35.0 kg/m2 in the presence of at least one obesity-related
comorbidity, who underwent either RYGBP or SG as a
primary bariatric procedure at University College London
Hospitals (UCLH) Centre for Weight loss, Metabolic and
Endocrine Surgery, London, UK or at the Obesity Centre of
the University Hospital of Pisa (UHP), Pisa, Italy were
included in the study. In both centres, the decision for
procedure selection was based on informed patient prefer-
ence after standardised counselling including details, risks,
and benefits of each procedure. Patients were advised to
follow a liquid diet for 2 weeks postoperatively, followed by
softer foods for 2 weeks, before resuming a solid diet
thereafter. The postoperative follow-up schedule for
patients in both centres comprised appointments at 6 weeks,
then 3 monthly during the first year and 6 to 12 monthly
thereafter, for a minimum of two postoperative years.
Surgical technique: RYGBP
In both centres, RYGBP was performed using a laparo-
scopic, antecolic, antegastric RYGBP. At the UCLH cen-
tre, 30–40 ml gastric pouch was fashioned, and the
alimentary limb was measured at 120 cm. The omentum
was divided longitudinally, and a stapled jejunojejunal
anastomosis was performed. In the UHP centre, a subcar-
dial gastric pouch with a 30–50-ml capacity was created,
and an enteroenterostomy was performed at 150 cm on the
alimentary limb.
Surgical technique: SG
In each centre, SG was performed using a standard lapa-
roscopic technique. In the UCLH centre, the sleeve was
created around the bougie using a laparoscopic stapler,
2.0 mm staple height on the gastric antrum and body and
1.8 mm staple height for the rest of the stomach, with
staple line reinforcement. In the UHP centre, a four-fifths
vertical gastrectomy was performed on a 34-French bougie
using multiple reinforced 60-mm linear stapler firings
starting 4–6 cm from the pylorus up to the gastroesopha-
geal junction.
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Measures
Demographic, anthropometric, and clinical data were col-
lected from electronic clinical data records. Age was
defined as the difference between the date of birth and date
of surgery. Baseline BMI was calculated from the weight
and height measurements recorded on the day of surgery.
Postoperative weight loss was determined relative to
weight on the day of operation. Percentage weight loss
(%WL) was chosen as the outcome measure for weight
change, as %WL is less influenced by baseline BMI than %
excess weight loss or BMI change, thereby facilitating a
more sensitive identification of novel predictors of weight
outcome [25]. Weight loss velocity (WLV) in the early
postoperative period (0–6 months) was expressed as kg lost
per week between postoperative follow-up appointments,
i.e. during 0–6 weeks, 6 weeks to 3 months and
3–6 months.
Statistical analysis
Baseline differences between patients in each bariatric
centre were assessed using two-tailed t tests or v2 tests as
appropriate. Linear regression analyses were performed to
determine the association of early postoperative weight
loss with maximal and 2-year %WL. Multiple regression
analyses were performed with maximal %WL as the out-
come measure, including adjustment for baseline variables.
Using backward selection, variables with P \ 0.05 were
retained in the models. A receiver operating characteristic
(ROC) curve was plotted in order to identify the optimal
cutoff point for early postoperative WLV in predicting
maximal %WL outcome. We chose a target %WL of 20 %
for this analysis, as %WL not reaching this target is likely
to represent a disappointment for the vast majority of
patients [26]. The optimal cutoff value was determined
using Youden’s index, i.e. by maximizing the point on the
ROC curve furthest from the line of equality. Analyses
were performed with StataTM software, version 13 (Stata-
Corp, TX, USA).
Results
Baseline patient characteristics
A total of 1,456 adults (Table 1) underwent either RYGBP
(n = 918) or SG (n = 538) as a primary procedure. There
were significant group differences in age, baseline BMI,
and diabetes status between centres. In relation to the SG
group, age was significantly higher in the UHP centre than
the UCLH centre (P \ 0.001) (Table 1). In relation to the
RYGBP group, baseline BMI was significantly higher in
the UHP centre than the UCLH centre (P \ 0.001),
whereas the proportion of patients with T2D (P = 0.03)
was significantly higher in the UCLH centre than the UHP
centre. There were no significant group differences in
gender distribution between centres. Maximal weight loss
data were calculated for 877 (95.5 %) patients who
underwent RYGBP and 513 (95.3 %) patients who
underwent SG, with weight data available for 715 (77.9 %)
patients in the RYGBP group and 390 (72.5 %) patients in
the SG group at the 2-year postoperative appointment.
%WL following RYGBP and SG
There was a marked variability in maximal %WL (Fig. 1)
following both RYGBP (mean 32.9 %, range 4.1–60.9 %)
and SG (mean 26.2 %, range 1.1–58.3 %). Maximal %WL
occurred at the 12-month follow-up appointment in
approximately one-third of patients in both RYGBP and
SG groups (Table 2). However, a higher proportion of
patients in the RYGBP group experienced maximal %WL
at the 24-month appointment, with lower proportions than
the SG group at the 6- and 9-month appointments
(P \ 0.001). In order to visualize the distribution of weight
loss trajectories, normative charts were constructed based
on percentiles of %WL at postoperative timepoints and
showed similar weight loss variability for both RYGBP and
SG patients (Fig. 2).
Association of early postoperative %WL with maximal
%WL
In order to investigate whether early postoperative weight
loss predicted the ultimate weight loss response, linear
regression analyses were performed with maximal %WL as
the outcome (Table 3). %WL at 6 weeks, 3 and 6 months
was significantly associated with maximal %WL for
patients in both RYGBP and SG groups (Fig. 3). The
associations of early postoperative %WL with maximal
%WL were stronger for SG than RYGBP at all three
postoperative timepoints examined, but most notably at
6-week and 3-month assessments (Table 3).
Association of early postoperative WLV with maximal
and 2-year %WL
Next, we examined the relative importance of weight loss
during specific time intervals in the early postoperative
period in relation to the maximal %WL achieved. In order to
determine this, WLV during the 0–6 weeks, 6 weeks to
3 months, and 3–6 months postoperative time periods was
used in linear regression analyses. We observed procedure-
specific temporal differences in the strength of association
between postoperative WLV and maximal %WL (Fig. 4). In
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the SG group, WLV during the 0–6 weeks and 6 weeks to
3 months postoperative periods predicted 18 and 21 % of
the variability in maximal %WL respectively, increasing to
26 % for the 3–6 month period (Table 3). Whereas in the
RYGBP group, WLV during the 0–6 week period and
6 weeks to 3 months period accounted for only 12 and 10 %
of the variability in maximal %WL, respectively, increasing
markedly to 32 % for the 3–6 month period (Table 3). Early
postoperative WLV associations with 2-year %WL were
comparable with those for maximal %WL (Table 4).
Multiple linear regression analyses
Multiple linear regression analyses including baseline vari-
ables of age, sex, preoperative BMI, diabetes, ethnicity and
bariatric surgery centre revealed that 3–6 months WLV,
baseline BMI, and age were independent predictors of maxi-
mal %WL for both SG and RYGBP groups (Table 4). In
addition, gender and T2D were independently associated with
maximal %WL in the RYGBP group, while ethnicity and
bariatric centre were independently associated with 1-year
%WL in the SG group. However, in comparison with baseline
variables, 3–6 month WLV was the strongest predictor of
maximal %WL following RYGBP and SG (Table 5).
A ROC curve (Fig. 5) was constructed to determine the
point at which 3–6 month WLV predicted maximal %WL
(using a target %WL of 20 %) with the best sensitivity/
specificity combination. The inflection point corresponded
to a sensitivity of 80 % and a specificity of 72 %. Using
this cutoff, which occurred at a WLV of 0.4667 kg/week
(1 lb/week), the maximal %WL outcome was classified
correctly for 79 % of patients.
Discussion
The findings in our study provide novel insights into the
weight loss response experienced both after RYGBP and
Table 1 Baseline demographic, clinical, and anthropometric characteristics
All UCLH UHP P
RYGBP SG RYGBP SG RYGBP SG
All 918 538 436 443 482 95 \0.001a
Women 711 (77 %) 393 (73 %) 350 (80 %) 319 (72 %) 361 (75 %) 74 (78 %) 0.75a
Men 207 (23 %) 145 (27 %) 86 (20 %) 124 (28 %) 121 (25 %) 21 (22 %)
T2D 274 (30 %) 188 (35 %) 145 (33 %) 150 (34 %) 129 (27 %) 38 (40 %) 0.06a
Ethnicity
White 824 (90 %) 439 (82 %) 342 (78 %) 344 (78 %) 482 95
Other 94 (10 %) 99 (18 %) 94 (22 %) 99 (22 %) – –
Mean age ± SD (years) 43.8 (10.6) 46.5 (11.1) 43.8 (11.9) 44.7 (10.4) 43.7 (10.1) 54.5 (10.5) 0.04b
Mean BMI ± SD (kg/m2) 48.3 (7.7) 49.8 (8.8) 46.0 (5.7) 50.0 (9.1) 50.3 (8.6) 48.6 (7.6) \0.001b
a Procedure and sex distribution, and T2D status were compared between centres using Pearson’s v2 tests
b Comparisons of mean age and BMI between centres were performed using unpaired two-tailed t tests
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Fig. 1 Histogram of maximal %WL for patients in RYGBP
(n = 877) and SG (n = 513) groups
Table 2 Timing of maximal %WL
Postoperative months RYGBP SG
N % N %
6 78 9 70 14
9 96 11 88 17
12 324 37 188 37
18 175 20 100 19
24 204 23 67 13
Pa \0.001
a Distribution of patients with maximal %WL across postoperative
timepoints was compared between procedures using a v2 test for
trend—a higher proportion of RYGBP patients experienced maximal
%WL at the 24-month appointment, with lower proportions than the
SG group at the 6- and 9-month appointments (important differences
in bold)
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SG. Patients who underwent either SG or RYGBP expe-
rienced a wide variability in weight loss during the first two
postoperative years. In a particularly novel aspect of the
study, the variability in maximal weight loss was shown to
be strikingly similar between procedures. Furthermore, the
results demonstrate that early postoperative weight loss is a
key predictor of ultimate weight loss response, with a
greater effect on outcome than several well-established
baseline clinical factors such as preoperative BMI, age,
sex, and diabetes.
Interestingly, our results show temporal procedure-specific
differences in the relationship between early postoperative
weight loss, expressed as %WL or WLV, and maximal weight
loss. In the immediate postoperative period (6 weeks post-
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Fig. 2 Normative charts of weight loss trajectories, based on
percentiles of %WL at standard postoperative timepoints for patients
in RYGBP (A) and SG (B) groups
Table 3 Strength of associations (r2) between maximal %WL and early postoperative %WL, at 6 weeks, 3 and 6 months (left panel), or WLV
during 0–6 weeks, 6 weeks to 3 months, and 3–6 months (right panel)
r2 P r2 P
SG SG
6-week %WL 0.21 \0.001 WLV 0–6 weeks 0.18 \0.001
3-month %WL 0.46 \0.001 WLV 6 weeks to 3 months 0.21 \0.001
6-month %WL 0.69 \0.001 WLV 3–6 months 0.26 \0.001
RYGBP RYGBP
6-week %WL 0.12 \0.001 WLV 0–6 weeks 0.14 \0.001
3-month %WL 0.23 \0.001 WLV 6 weeks to 3 months 0.10 \0.001
6-month %WL 0.53 \0.001 WLV 3–6 months 0.32 \0.001
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Fig. 3 Scatterplots with maximal %WL as the outcome, and %WL at
6 weeks, 3 or 6 months as the predictor for patients in RYGBP and
SG groups, with respective lines of best fit
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Fig. 4 Scatterplots with maximal %WL as the outcome, and WLV
during 0–6 weeks, 6 weeks to 3 months, or 3–6 months time
intervals, as the predictor for patients in RYGBP and SG groups,
with respective lines of best fit
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surgery), %WL is a stronger predictor of maximal weight loss
in the SG group compared to the RYGBP group. Similarly, the
strength of the association between %WL in the first three
postoperative months and maximal weight loss in the SG
group was approximately twice that observed in the RYGBP
group. In order to identify which postoperative time period
may best predict ultimate weight loss outcome, we examined
WLV during specific postoperative time intervals, a concept
which has been previously applied in a study of RYGBP
outcomes [21]. WLV experienced in the 3–6 month postop-
erative period was a stronger predictor of maximal weight
loss, compared to the earlier postoperative time intervals, for
both SG and RYGBP groups. However, in the RYGBP group,
the strength of the association with maximal weight loss was
approximately threefold higher for the 3–6 month postoper-
ative period compared to the earlier postoperative time
intervals, but only approximately 25–50 % higher in the SG
group. Taken together, these findings support the concept that
both distinct and overlapping biological mechanisms underlie
the benefits of SG and RYGBP [27, 28].
Our findings have several potential clinical implications for
patients undergoing either SG or RYGBP. Firstly, focus on
early postoperative WLV is an effective means of identifying
patients whose weight loss is ultimately suboptimal. Our ROC
analysis demonstrates that approximately four out of every five
patients who lose less than a 1 lb a week during the 3–6 month
postoperative period will not achieve a maximal %WL of more
than 20 %. Such patients could be targeted for early postop-
erative behavioural or intensive lifestyle interventions known
to improve weight outcome after surgery [22–24], thereby
providing an opportunity to enhance their maximal weight
loss. Our results provide a basis for randomized trials of
behavioural or exercise interventions initiated early in the
postoperative course for both RYGBP and SG patients.
Secondly, the wide variability in weight loss response,
previously demonstrated only in RYGBP patients [8, 9], is
similar for both procedures. Therefore, bariatric health care
professionals should alert patients who are considering sur-
gery to this inherent variability as part of the informed con-
sent process. In this regard, our normative charts provide a
useful reference for expected weight loss trajectories post-
SG or RYGBP and are consistent with the results of a pre-
vious single-centre study in RYGBP patients [21]. The
practice of providing advice to patients regarding expected
weight loss based on an average narrow range [29] is likely to
be counterproductive, ultimately leading unnecessarily to a
sense of disappointment or failure for many patients [26].
Indeed, a poor weight loss response is likely to merely reflect
an outcome at the lower tail of a normal distribution driven
by a multitude of complex biological factors [7, 30]. Patients
should be advised as such preoperatively and be relieved of
any sense of blame if necessary in the postoperative setting.
Thirdly, our findings are consistent with the strong
biological basis that underlies the benefits of bariatric
Table 4 Strength of associations (r2) between 2-year %WL and
WLV during 0–6 weeks, 6 weeks to 3 months, and 3–6 months
r2 P
SG
WLV 0–6 weeks 0.08 \0.001
WLV 6 weeks to 3 months 0.29 \0.001
WLV 3–6 months 0.31 \0.001
RYGBP
WLV 0–6 weeks 0.11 \0.001
WLV 6 weeks to 3 months 0.21 \0.001
WLV 3–6 months 0.40 \0.001
Table 5 Results of multiple regression analyses, after backward selection, with maximal %WL as the outcome measure, and expressed with
standardised effect sizes (b-coefficient)
SG Standardised b-coefficient P RYGBP Standardised b-coefficient P
WLV 3–6 months 0.51 \0.001 WLV 3–6 months 0.52 \0.001
Baseline BMI -0.19 \0.001 Age -0.09 0.003
Age -0.18 \0.001 T2D -0.08 0.005
Centre 0.16 \0.001 Baseline BMI 0.08 0.008
Ethnicity 0.09 0.015 Male sex -0.07 0.008
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Fig. 5 ROC demonstrating the ability of WLV during the 3–6 month
time interval to predict maximal %WL C20 % expressed as area
under curve (AUC). The inflection point (asterisk) corresponded to a
sensitivity of 80 % and a specificity of 72 %
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surgery [31]. Indeed, the weight loss response to RYGBP is
known to be highly heritable [32], suggesting that patients’
responses to bariatric surgery may, to a large extent, be
predetermined by their genotype. Genome-wide associa-
tion studies have demonstrated associations of common
genetic variants with 1-year weight loss response in
patients after RYGBP [30, 33]. However, personalized
medicine, like in many clinical specialties, has thus far had
limited clinical impact, if any, in the field of bariatric
surgery [34]. In this light, our findings suggest that an
individual’s maximal weight loss response to SG or RY-
GBP may be most practically predicted by tracking their
actual weight change in the early postoperative period.
A potential limitation of our study is the focus on maximal
weight loss. However, this is clearly an important outcome for
patients who undergo bariatric surgery [26]. Moreover, weight
regain subsequent to the maximal weight loss achieved is likely
to reflect a completely different biological process from that
governing the initial weight loss. Such weight regain is subject
to a multitude of biological, psychological, and environmental
influences, and remains poorly defined [35]. In order to address
a definable research question, we focused on maximal weight
loss response and not subsequent weight change. Prediction of
late weight regain after bariatric surgery may be equally
important; however, maximization of the initial weight loss
response is clearly central to optimizing long-term outcome [8,
36]. Interestingly, we found that in addition to being associated
with maximal %WL, early postoperative WLV was also
associated with 2-year %WL. These findings suggest that early
WLV predicts longer-term postoperative weight loss outcomes
but longer-term studies are required to confirm this. Another
interesting question not addressed by our study is whether early
postoperative weight loss also predicts resolution of comor-
bidities. However, the benefits of bariatric surgery in amelio-
rating obesity-related comorbidities are in proportion to the
weight loss achieved [36]. Finally, a further potential limitation
is the difference in baseline patient characteristics between
bariatric centres. In particular, the population of patients who
underwent SG in the UHP centre was significantly different
from SG patients in the UCLH centre (smaller sample size and
older age). This difference may, in turn, have contributed to the
finding that centre predicted maximal weight loss in the SG
group but not the RYGBP group. This limitation was unlikely
to affect the robust association of early postoperative weight
loss with maximal weight loss, and we believe the study ben-
efits from its multicentre dimension.
Conclusions
Our results demonstrate that there is a wide variability in
weight loss response after both RYGBP and SG. Moreover,
patients who ultimately experience suboptimal weight loss
after either procedure can be identified based on early
postoperative weight loss, within the first six postoperative
months and primarily during the 3–6 month postoperative
period, offering the opportunity for adjunctive interven-
tions that could enhance their weight loss response.
Detailed characterization of weight loss trajectories also
provides an impetus to enhance bariatric care pathways
with a greater emphasis on promoting understanding of
expected outcomes among clinicians and patients alike, as
well as patient-centred approaches to maximizing the
benefits of these highly effective interventions.
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